AI-derived software in screening for breast cancer
The Breast Imaging Group in the Department of Medical Imaging at the Radboud University Medical Center in the Netherlands is widely renowned for its work in the improvement and evaluation of radiological techniques for the detection and monitoring of breast cancer. Recently the group has been evaluating an AI‐generated software package from the Dutch company Screenpoint for the detection of cancerous lesions in the breast. We wanted to find out more about the department in general and their experience of Screenpoint’s Transpara algorithm in particular, so we spoke to Dr. Ritse Mann, breast radiologist and head of the Breast Imaging Group.
The Institute of Diagnostic and Interventional Radiology in the University Hospital Zurich, Switzerland has been the longest-standing user of a dedicated new breast CT system equipped with a photon-counting detector. The team have just published a paper on the use of the new system in patients with breast implants . We spoke to Prof. Andreas Boss, Senior Consultant responsible for breast imaging
Founded more than 700 years ago, the Basel University Hospital is one of the oldest hospitals in Switzerland. Despite its venerable age, the hospital has a deserved reputation for using the most upto-date technology whenever clinically appropriate. An example of this is the recent acquisition of a small, 0.55 Tesla, wide-bore MRI scanner, the Magnetom Free.Max from Siemens Healthineers. We wanted to find out more about the clinical experience with the new system so far and the potential of low-field MRI in general, so we spoke to Prof. Elmar Merkle, head of the Department of Radiology, together with Dr. Hanns-Christian Breit and Dr. Michael Bach